Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Dold

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 7, 2016
Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers - A pharmacoepidemiological cross-sectional multicenter studyMarkus Dold, Alexander Kautzky, Lucie Bartova, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 23, 2019
Comorbid hypertension in patients with major depressive disorder - Results from a European multicenter studyGernot Fugger, Markus Dold, Lucie Bartova, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 6, 2019
Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant DepressionGernot Fugger, Markus Dold, Lucie Bartova, et al.
Journal of Affective Disorders|October 15, 2021
Pregabalin augmentation of antidepressants in major depression - results from a European multicenter studyMarkus Dold, Lucie Bartova, Gernot Fugger, et al.
Journal of Psychiatric Research|July 3, 2021
Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant DepressionLucie Bartova, Gernot Fugger, Markus Dold, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|April 20, 2023
Age as a moderating factor of treatment resistance in depressionAlexander Kautzky, Lucie Bartova, Gernot Fugger, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|July 26, 2019
Results of the European Group for the Study of Resistant Depression (GSRD) - basis for further research and clinical practiceLucie Bartova, Markus Dold, Alexander Kautzky, et al.
JAMA Psychiatry|May 3, 2014
Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analysesMaximilian Huhn, Magdolna Tardy, Loukia Maria Spineli, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 27, 2025
Symptom networks in major depressive disorder and treatment response: special focus on TRDAlexander Kautzky, Lucie Bartova, Markus Dold, et al.
The Journal of Clinical Psychiatry|December 12, 2017
Refining Prediction in Treatment-Resistant Depression: Results of Machine Learning Analyses in the TRD III SampleAlexander Kautzky, Markus Dold, Lucie Bartova, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 7, 2016
Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers - A pharmacoepidemiological cross-sectional multicenter studyMarkus Dold, Alexander Kautzky, Lucie Bartova, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 23, 2019
Comorbid hypertension in patients with major depressive disorder - Results from a European multicenter studyGernot Fugger, Markus Dold, Lucie Bartova, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 6, 2019
Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant DepressionGernot Fugger, Markus Dold, Lucie Bartova, et al.
Journal of Affective Disorders|October 15, 2021
Pregabalin augmentation of antidepressants in major depression - results from a European multicenter studyMarkus Dold, Lucie Bartova, Gernot Fugger, et al.
Journal of Psychiatric Research|July 3, 2021
Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant DepressionLucie Bartova, Gernot Fugger, Markus Dold, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|April 20, 2023
Age as a moderating factor of treatment resistance in depressionAlexander Kautzky, Lucie Bartova, Gernot Fugger, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|July 26, 2019
Results of the European Group for the Study of Resistant Depression (GSRD) - basis for further research and clinical practiceLucie Bartova, Markus Dold, Alexander Kautzky, et al.
JAMA Psychiatry|May 3, 2014
Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analysesMaximilian Huhn, Magdolna Tardy, Loukia Maria Spineli, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 27, 2025
Symptom networks in major depressive disorder and treatment response: special focus on TRDAlexander Kautzky, Lucie Bartova, Markus Dold, et al.
The Journal of Clinical Psychiatry|December 12, 2017
Refining Prediction in Treatment-Resistant Depression: Results of Machine Learning Analyses in the TRD III SampleAlexander Kautzky, Markus Dold, Lucie Bartova, et al.
Pageof 7